Dr Bassel Wattar

Clinical Services

Embark on my inspiring journey, from my foundational training received in Devon to my current specialization in obstetrics and gynaecology

Expert in Women's Health and Fertility Care

I’m a leading fertility specialist with expertise in assisted conception, menstrual disorders, and menopause management. Practices in the UK NHS and leads an endocrine genecology service. I perform advanced surgeries for subfertility and gynecologic conditions. My passion lies in providing individualized care for a broad range of women’s health needs.

Fertility and Assisted Conception

Assisted conception encompasses a wide range of treatments from ovulation induction, timed coitus, Intra-Uterine Insemination (IUI), Donor Insemination (DI), Intra Cytoplasmic Sperm Injection (ICSI), In Vitro Fertilisation (IVF) and fertility preservation. While assisted conception is becoming widely available, serious concerns are emerging about exposing patients to unnecessary expensive IVF add-ons that do not have proof behind them. Similarly, mass provision of IVF treatment (the conveyer belt approach) often leads to unsatisfactory experience. It is important to understand the unqiue health needs of each patient with subfertility to help them access the most suitable individualised assisted conception treatment for them.

Fertility check and Social egg freezing

Social egg freezing, also known as elective or non-medical egg freezing, refers to the process of preserving a woman’s eggs for future use without any medical indication. The decision to pursue social egg freezing is a personal one, and whether it is a good idea depends on individual circumstances and priorities. Here are some factors to consider such as age and fertility, personal circumstances, emotional and financial considerations depending on your preferences, values, and circumstances. It’s important to assess your personal fertility chances to form a personalized guidance based on your specific situation.

Male fertility

Male infertility refers to the inability of a man to impregnate a female partner despite having frequent, unprotected sexual intercourse for a year or longer. It is estimated that nearly 1 in 7 couples experience infertility, with male infertility playing a role in up to half of these cases. male infertility can be a complex issue with multiple contributing factors. A comprehensive evaluation can help identify the specific causes of male infertility, and various treatments are available to address these issues. These treatments may include medication, surgery, assisted reproductive techniques (such as artificial insemination, in vitro fertilization, or intracytoplasmic sperm injection), or lifestyle modifications

Ovulatory disorders and ovulation induction

One of the most common causes of female infertility is ovulatory disorder, which include irregular ovulation or no ovulation. No ovulation is usually associated with complete lack of menstruation. Disruptions of any of the ovulation processes can lead to ovulatory disorders. For example, patients with polycystic ovarian syndrome (PCOS) often have chronically elevated levels of androgens that prevent successful ovulation. Also, women of advancing age may experience reduced ovarian reserve (fewer viable eggs that can fertilize and develop normally) leading to anovulation. Early diagnosis is key to enable rapid mangement and provision of treatments to correct any hormonal imbalance.

Polycystic ovary syndrome

Polycystic ovary syndrome (PCOS) is a health problem that affects 1 in 10 women of childbearing age. The symptoms of PCOS can vary among individuals, but commonly include irregular or absent menstrual periods, excessive hair growth (hirsutism), acne, and weight gain. PCOS can also lead to fertility issues, as the lack of regular ovulation makes it difficult for women to conceive. Additionally, long-term complications such as type 2 diabetes, high blood pressure, and heart disease may be more common in women with PCOS.

Adopting a healthy lifestyle with several other simple interventions can offer effective longterm mangement of this condition and limit its adverse effects

Heavy and irregular periods

Heavy menstrual bleeding (HMB) affects one in four women of reproductive age leading to significant impairment of their quality of life. The cause of HMB remains unknown in the majority of affected women and about 50000 women in England and Wales seek specialist treatment at secondary care services annually. This constitutes approximately 20% of referrals to the National Health Service (NHS) gynaecology services, and about 28000 women eventually require surgery to manage their HMB. Several treatment options are offered for HMB including medical options (e.g. progestogen-releasing Intra-Uterine Systems (IUS), contraceptive pills, Danazol, Ulipristal acetate, nonsteroidal anti-inflammatory drugs, anti-fibrinolytic agents, gonadotropin-releasing hormone agonists) and surgical options (e.g. endometrial ablation, hysterectomy (open, vaginal, subtotal, and laparoscopic.

Fibroids, endometriosis and pelvic pain

Many women are affected by uterine fibroids, endometriosis, adenomyosis which can reduce their fertility and expose them to very painful periods. Having access to reliable diagnostic scanning facilities is important to assess the impact of these conditions and how they can be best managed on the longterm. Several new medical treatments are now emerging which is helping women to cope with the longterm effects of endometriosis and adenomyosis. Similarly, minimally invasive surgery has now advanced to enable keyhole removal of fibroids without having to undergo major open surgery. 

PMS and Menopause

Menopause is a natural phenomenon associated with the reduction or cessation of natural oestrogen from the ovaries often leading to varied symptoms of hot flushes, night sweats, brain fog, muscle and joint pain, low mood, irritability, reduced libido, and vulvovaginal dryness. By 2050, it is estimated that 1.6 billion women worldwide will be in the post-reproductive menopause phase with >75% reporting severe vasomotor symptoms that negatively impact their quality of life. Left unmanaged, menopausal symptoms can have a detrimental effect on women’s wellbeing, mental health, and their effective participation at the workplace. While many treatment options exist, menopause hormone therapy (MHT) remains the most effective treatment for menopausal symptoms. It important to counsel each woman with menopause on the risks and benefits of available hormonal and non-hormonal treatment option to help them choose the most convenient option that would help them to optimise their quality of life in the post-reproductive years.

I care for private patients at
these clinics 👉

I care for both self-funding and insured patients and I hold recognition with a wider number of insurance providers (AXA, Aviva, Vitality, Bupa, Cigna, Healix, WPA)

To book an appointment please contact my secretary: 02031376093